Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says
Adds shortage details in paragraph 3, details on HHS response in paragraph 9, 10
Oct 9 (Reuters) -The closure of Baxter International's BAX.N North Cove facility in North Carolina following Hurricane Helene could further limit the supply of intravenous fluids, the U.S. Department of Health and Human Services said on Wednesday.
The company, one of the four main U.S. suppliers of IV fluids, had on Sept. 29 said production at the site has been shut due to flooding. It added it was working with the government to assess the damage and bring the plant back online.
On Tuesday, the U.S Food and Drug Administration said two doses of Baxter's Dextrose solutions for low blood sugar and a saline solution are in shortage.
Meanwhile, HHS said it has also considered the possibility of Hurricane Milton further disrupting the IV fluid supply chain and was working to move the product away from the projected path of the storm.
Baxter has said it aims to restart production in phases and return to 90% to 100% allocation of certain IV solutions by the end of 2024.
The company said it was also increasing the U.S. allocation of its highest demand IV fluids for direct customers to 60% from 40% and for distributors to 60% from 10%, effective Oct. 9.
Germany's Fresenius FREG.DE said on Tuesday it was checking options to start new infusion-solution production lines faster than planned at a North Carolina facility to help mitigate the potential shortages.
The U.S. health department said it is working with other domestic IV solutions manufacturers to combat the supply crunch.
Reporting by Christy Santhosh in Bengaluru; Editing by Leroy Leo, Arun Koyyur and Sriraj Kalluvila
免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。
所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。
本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。
